Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2.
SARS-CoV-2-caused COVID-19 instances are rising globally, calling for growing efficient therapeutics to regulate the present pandemic. SARS-CoV-2 and SARS-CoV acknowledge angiotensin-converting enzyme 2 (ACE2) receptor through the receptor-binding area (RBD).…